International Flavors & Fragrances Inc (IFF) (Q3 2026) Earnings Call

International Flavors & Fragrances Inc (IFF) reported challenges in its Health business due to reduced consumer spending in the US and Europe. The company expects higher costs in Q4 2026, with net price to input costs remaining unfavorable. Profitability margins are expected to moderate due to seasonality and higher costs. IFF faces execution risks related to the separation of its Food Ingredients business.

Original reporting

finance.yahoo.com

Published Nov 7, 2026, 1:04 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Nov 7, 2026, 1:14 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

Source · finance.yahoo.com

Decision brief

The 30-second read

$IFFBearishMed

Why it matters

The guidance points to near‑term earnings pressure but highlights growth in Consumer Fragrance and Taste segments.

Market read

Investors will reassess IFF's valuation as cost pressures may compress earnings, while growth in niche segments offers upside.

What to watch

The launch of GutABAlite and GLP‑1 driven taste opportunities may offset some margin drag in the longer term.

Relevance 7/10Novelty 7/10Timing: today

Background

IFF's Q3 2026 earnings call provided detailed guidance for Q4, focusing on cost inflation, margin outlook, and strategic initiatives.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$IFFBearishHigh confidence

Context

IFF disclosed Q4 2026 guidance showing higher costs, unfavorable price-to-input gap and margin moderation.

Expected impact

likely downside as investors price in higher input costs and lower margins

Evidence & confidence

The call highlighted cost inflation and margin compression, which typically depresses the stock until mitigation steps are seen.

Market effects

Sector

Health & Biosciences and Food Ingredients segments face cost headwinds, potentially affecting peers in specialty chemicals.

Regional

US and European consumer markets may see slower demand for dietary supplements, influencing related consumer‑goods stocks.

Global

Higher oil‑derived input costs could ripple through commodity‑linked industries worldwide.

Counterpoint

What could challenge this read

If IFF successfully accelerates pricing actions and cost productivity, the stock could rebound despite short‑term pressure.

Key entities

Executive
J. Erik Fyrwald
CEO of IFF, discussed market softness and growth initiatives.
Executive
Michael DeVeau
CFO of IFF, detailed cost inflation and pricing strategy.

Read at source ← All news

$IFFMedAI 8/10

International Flavors & Fragrances Q3 Earnings Call Highlights

International Flavors & Fragrances (IFF) reported Q3 sales of $566M in Health & Biosciences, up 1%. Full-year sales are expected to be $7.5B-$7.6B, with adjusted EBITDA of $1.55B-$1.6B. IFF faces cost pressures, particularly in Health & Biosciences, due to higher input costs. The company plans to divest its Food Ingredients business for $4.3B by mid-2027 and has completed other divestitures. Free cash flow for the first nine months of 2026 was $371M, up $245M year-over-year.

finance.yahoo.comNov 8

$IFFMed

International Flavors & Fragrances double-downgraded to Sell equivalent at BofA (IFF:NYSE)

International Flavors & Fragrances (IFF) shares dropped 3.3% after BofA double-downgraded the stock to Underperform from Buy, citing a lack of near-term catalysts and reducing the price target to $91 from $95. The company's recent rally was noted as a factor.

seekingalpha.comNov 6

$IFFHigh

BofA downgrades International Flavors & Fragrances stock rating on valuation concerns

BofA downgraded International Flavors & Fragrances (IFF) to Underperform, lowering its price target to $91. IFF reported Q3 adjusted EBITDA of $403M, beating estimates. Despite strong results, BofA cited valuation concerns, softness in non-Taste businesses, and rising costs. IFF's stock declined post-earnings due to near-term margin concerns, though management raised full-year guidance.

investing.comNov 6

$IFFHighAI 8/10

Intl Flavors (IFF) Q3 2026 Earnings Call Transcript

Intl Flavors (IFF) reported Q3 2026 earnings with 5% revenue growth and 6% EBITDA increase, driven by strong performances in taste and scent segments. The company raised its full-year guidance, completed a $500M share repurchase, and announced strategic divestitures, including the sale of its food ingredients business for $4.3B. Free cash flow rose to $371M, up $245M YoY. IFF expects near-term softness in Health & Biosciences but remains confident in its growth strategy.

finance.yahoo.comNov 4

$IFFMedAI 9/10

IFF Q3 2026 slides: solid growth tempered by margin headwinds

International Flavors & Fragrances (IFF) reported Q3 2026 earnings with revenue of $1.94B and adjusted EPS of $0.83, beating expectations. Shares fell 3.83% due to margin concerns and guidance for softer Q4 profitability. IFF highlighted growth in Taste, Scent, and Health & Biosciences segments, along with a $4.3B sale of its Food Ingredients business and a $2.5B capital return program. Free cash flow improved to $371M, up $245M YoY.

investing.comNov 4